MENQUADFI
SANOFI
Identification
- Active ingredient (INN)
- VACCIN MENINGOCOCCIQUE CONJUGUE DES GROUPES A,C,W ET Y
- Internal code
- 13 U 532
- Country of Origin
- France
- Pharmaceutical form
- Injectable Solution
- Prescription List
- Highly Regulated (List I)
- Packaging
- b/01 et b/05
DAWA Clinical Workbench v2.0
Information may not be accurate. Always consult a physician, pharmacist, or specialist before acting on any data shown here.
Description
Meningococcal group
A polysaccharide is group-specific polysaccharide antigens extracted and purified from Neisseria meningitidis serogroup A.
It is
Subcutaneous administered as an active immunization against the invasive meningococcal disease caused by the serogroup A.
Indications
Not Available
Adverse Effects
Improve decision support & research outcomes With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates.
View sample adverse effects data in our new Data Library! See the data Improve decision support & research outcomes with our structured adverse effects data.